** Shares of biotech firm Bio-Techne TECH.O fall 12.8% to $49.42

** Co posts Q1 revenue of $311.4 million, below analysts' estimate of $317.1 million, according to LSEG data

** Sales at TECH's largest protein sciences unit fell 1% to $226.2 million

** "We expect shares to respond negatively to TECH's print, and expect the focus to be on whether TECH can exit FY26 with mid-single-digit growth," Leerink Partners says

** Evercore ISI expects to see a rebound in FY’27 driven by benefit from biotech funding recovery

** Co posts adjusted profit per share of 53 cents for the quarter, missing estimates of 54 cents.

** Including session's move, TECH down 15.4% YTD